Delivery Order SPE2DB22D1052-SPE2DB24FU9UD
Award Date
9/17/24
Potential Completion Date
10/8/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,835.28 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 20, 2025, with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The $1,188.34 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 14, 2024, with a completion date of September 5, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,565.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024, with a completion date of September 30, 2024. The contract has no set-aside designation. As a large supplier of pharmaceuticals and medical supplies to the U.S. federal government, Amerisourcebergen holds...
This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The $2,376.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a performance period through July 1, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,752.92, is a delivery order for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product. The contract has a completion date of February 3, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The contract, valued at $4,917.64, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 11, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. This is a Firm Fixed Price delivery order contract that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of April 30, 2025. AmerisourceBergen...
The federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $4,753.36. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024, with a period of performance through December 6, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products. The fixed-price contract, valued at $2,458.82, has an ultimate completion date of April 3, 2025. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract, valued at $3,565.02, is a firm fixed price delivery order with an ultimate completion date of August 26, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award. The contract is part of...